Chlorpromazine, clotiapine and thioridazine--a comparative clinical trial on Bantu psychotic patients.
A.J. Van Wyk, G.F.T. Marais
Abstract
A.J. Van Wyk, G.F.T. Marais
Abstract
In a non-blind assessment of 3 neuroleptic drugs, chlorpromazine (Largactil), thioridazine (Melleril) and clotiapine (Etomine), we found Etomine to be the drug of choice when the diagnosis is in doubt between a toxic psychosis or schizophrenia. This drug also offered the highest discharge rate, 77'7% at 12 weeks compared with 73'5% in the thioridazine group, and 55'5% in the chlorpromazine group. No clouding of consciousness was seen in the clotiapine group, whereas it was troublesome in the chlorpromazine group in patients having received high parenteral doses.
OpenAlex reports 7 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
In a non-blind assessment of 3 neuroleptic drugs, chlorpromazine (Largactil), thioridazine (Melleril) and clotiapine (Etomine), we found Etomine to be the drug of choice when the diagnosis is in doubt between a toxic psychosis or schizophrenia. This drug also offered the highest discharge rate, 77'7% at 12 weeks compared with 73'5% in the thioridazine group, and 55'5% in the chlorpromazine group. No clouding of consciousness was seen in the clotiapine group, whereas it was troublesome in the chlorpromazine group in patients having received high parenteral doses.
Key concepts: Thioridazine, Chlorpromazine, Medicine, Perphenazine, Drug, Psychosis, Schizophrenia (object-oriented programming), Anesthesia